Challenge trials and tribulations- what’s next in the race to a SARS-CoV-2 vaccine?

‘Challenge trials’, where healthy volunteers are infected with a virus, are a mainstream tool in approaching vaccine development for diseases. However, the World Health Organisation’s (WHO) guidance on using challenge trials for the development of a Covid-19 vaccine has been received with some controversy, principally due to the lack of available knowledge on the virus.

Read more